Apparent mineralocorticoid excess (AME) syndrome is a rare genetic disorder characterised by excessive aldosterone production, a hormone that regulates electrolyte balance and blood pressure.
Excess aldosterone causes high sodium and low potassium levels in the blood, which can lead to a variety of health problems such as hypertension, hypokalemia, metabolic alkalosis, and heart arrhythmias.
Medical Exam Alert
This topic will help you solve some tough MCQs in medical exams like NExT Step 1&2, USMLE Step 1&2, MBBS, NEET PG, NCLEX and other medical exams.
The mindmap/concept map will also help you in remembering the important concepts of Apparent Mineralocorticoid Excess Syndrome very clearly during exams
Apparent Mineralocorticoid Excess Syndrome : [MEDNOTES+MINDMAP]
- Definition
- A rare disorder caused by mutations in the gene for 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2)
- Results in overproduction of the mineralocorticoid hormone, deoxycorticosterone (DOC)
- Can lead to hypertension and hypokalemia, as well as other symptoms such as edema, headaches, and muscle weakness
- Epidemiology
- Estimated incidence of 1 in 1,000,000
- More common in males than females
- Can occur in all ethnicities
- Natural history
- Symptoms typically begin in early childhood
- If left untreated, can lead to complications such as cardiovascular disease and end-organ damage (e.g. kidney damage)
- Can be effectively treated with mineralocorticoid receptor antagonists, such as spironolactone
- Classification
- Classic AME: caused by mutations in the HSD11B2 gene, results in overproduction of DOC
- Non-classic AME: caused by mutations in other genes, results in overproduction of other mineralocorticoids
- Mild, moderate, or severe depending on the level of mineralocorticoid hormone production and symptoms
Risk Factors
- Familial
- Genetic mutations in enzymes involved in mineralocorticoid metabolism (11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), aldosterone synthase (CYP11B2), and mineralocorticoid receptor)
- Drug-induced (licorice, carbenoxolone, metyrapone)
Etiology/Causes
- Defect in 11beta-HSD2 enzyme, leading to increased conversion of cortisone to cortisol and increased mineralocorticoid activity
- Mutations in CYP11B2 enzyme, leading to increased aldosterone production
- Mutations in mineralocorticoid receptor, leading to increased sensitivity to mineralocorticoids
Signs
- Hypertension
- Hyperkalemia
- Metabolic alkalosis
- Hypokalemic alkalosis
Symptoms
- Fatigue
- Weakness
- Muscle cramps
- Nausea
- Polyuria
Pathology/Pathogenesis
- Excess mineralocorticoid activity leads to increased sodium retention and potassium excretion by the kidneys, leading to hypertension and hyperkalemia
- Increased aldosterone production also leads to increased secretion of hydrogen ions in the distal tubules, leading to metabolic alkalosis.
- Low potassium levels in the body lead to increased secretion of hydrogen ions by the kidneys, leading to hypokalemic alkalosis.
- Progressive damage to the kidneys and other organs can occur due to chronic hypertension and electrolyte imbalances.
- Diagnosis
- Elevated levels of plasma renin activity (PRA) and aldosterone
- Low serum potassium levels
- High blood pressure
- Tests Required
- Plasma renin activity test
- Aldosterone-to-renin ratio test
- Serum potassium levels test
- Blood pressure test
- Associated with
- 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) deficiency
- Liddle’s syndrome
- Similar diseases/syndromes
- Conn’s syndrome
- Bartter’s syndrome
- Gitelman’s syndrome Treatment
- Surgery (for Liddle’s syndrome)
More
Alert !
Medical Info Disclaimer Click Here
Dr. Arin Nandi
Passionate About Medical Science & Helping Future Doctors Achieve Top Ranks In Medical Exams. He is professionally a dentist as well as a public health expert from JIPMER working in govt.health department
Author